Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma
Recruiting
  • Lymphoma
  • No Intervention
  • Hefei, Anhui, China
  • +23 more
2022-04-07
Apr 7, 2022
N
A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy, Including Boost...
Recruiting
  • Solid Tumor Malignancy
  • +4 more
  • mRNA-1273
  • Bethesda, Maryland
  • +1 more
2022-04-07
Apr 7, 2022
N
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
Recruiting
  • Lymphoma
  • +3 more
  • obinutuzumab
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Recruiting
  • Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
Recruiting
  • Epstein-Barr Virus Infections
  • +3 more
  • Nivolumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Pembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PCNSL), and Other Extranodal Diffuse Large B-cell Lymphomas
Active, not recruiting
  • Non-Hodgkin Lymphoma
  • +4 more
  • Pembrolizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
Recruiting
  • Leukemia
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    N
    Sample Collection and Tracking for the Developmental Therapeutics Clinic
    Recruiting
    • Neoplasms
    • Lymphoma
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2022-04-07
      Apr 7, 2022
      N
      Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
      Not yet recruiting
      • Lymphoma
      • Leukemia
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        2022-04-07
        Apr 7, 2022
        N
        Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas
        Recruiting
        • Solid Tumors
        • Lymphoma
        • Bethesda, Maryland
        • +1 more
        2022-04-07
        Apr 7, 2022
        N
        Vaccine Responses in Patients With B Cell Malignancies
        Not yet recruiting
        • Lymphoma
        • PNEUMOVAX 23
        • +9 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        2022-04-07
        Apr 7, 2022
        N
        Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins
        Completed
        • Lymphoma
        • Lymphoid Hyperplasia
          • Bethesda, Maryland
            National Cancer Institute (NCI), 9000 Rockville Pike
          2022-04-07
          Apr 7, 2022
          N
          A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas - 2017
          Completed
          • Neoplasms
          • Lymphoma
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          2022-04-07
          Apr 7, 2022
          N
          Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
          Recruiting
          • Prostate Cancer
          • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            2022-04-07
            Apr 7, 2022
            M
            In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies
            Recruiting
            • Acute Lymphocytic Leukemia
            • Lymphoma
            • Biological/Genetically Modified T cells
            • Cyclophosphamide-based chemotherapy
            • New York, New York
              Memorial Sloan Kettering Cancer Center
            2022-04-07
            Apr 7, 2022
            N
            Safety Study of Cord Blood Units for Stem Cell Transplants
            Recruiting
            • Aplastic Anemia
            • +3 more
            • Cord Blood Units
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            2022-04-07
            Apr 7, 2022
            N
            Agriculture Health Study
            Active, not recruiting
            • Prostate Cancer
            • +3 more
              • Iowa City, Iowa
              • +1 more
              2022-04-07
              Apr 7, 2022
              N
              Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
              Recruiting
              • Advanced Malignant Solid Neoplasm
              • +49 more
              • Birmingham, Alabama
              • +1423 more
              2022-04-06
              Apr 6, 2022
              M
              Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation
              Recruiting
              • Acute Lymphoblastic Leukemia
              • +3 more
              • Allogeneic Bone Marrow Transplantation
              • +10 more
              • Houston, Texas
                M D Anderson Cancer Center
              2022-03-31
              Mar 31, 2022
              C
              CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma
              Recruiting
              • Lymphoma, Non-Hodgkin
              • +6 more
              • CB-010
              • +2 more
              • Scottsdale, Arizona
              • +5 more
              2022-04-05
              Apr 5, 2022
              F
              Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study
              Not yet recruiting
              • Clinical Stage I Cutaneous Melanoma AJCC v8
              • +33 more
              • Informational Intervention
              • +4 more
              • Los Angeles, California
              • +4 more
              2022-04-04
              Apr 4, 2022
              T
              A Trial of TTI-622 in Patients With Advanced Hematologic Malignancies
              Recruiting
              • Lymphoma
              • +3 more
              • Los Angeles, California
              • +13 more
              2022-03-28
              Mar 28, 2022
              N
              Collection and Storage of Tissue and Blood Samples From Patients With Cancer
              Recruiting
              • Lymphoma
              • +6 more
              • Cytology Specimen Collection Procedure
              • Birmingham, Alabama
              • +139 more
              2022-04-05
              Apr 5, 2022
              D
              A Study of the Safety and Efficacy of EBV Specific T-cell Lines
              Recruiting
              • Epstein-Barr Virus Infections
              • +2 more
              • Group A
              • Group B
              • Montreal, Quebec, Canada
                Hôpital Maisonneuve-Rosemont
              2022-04-05
              Apr 5, 2022
              M
              Better Leukemia Diagnostics Through AI (BELUGA)
              Recruiting
              • Hematologic Malignancy
              • +4 more
              • Automated AI-Guided Diagnosis of Hematological Malignancies
              • Munich, Bavaria, Germany
                MLL Munich Leukemia Laboratory
              2022-04-04
              Apr 4, 2022